Activation of CB2R with AM1241 ameliorates neurodegeneration via the Xist/miR‐133b‐3p/Pitx3 axis

Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3−/−Mice, a Genetic Model of Parkinson's Disease

(2018) Luz M. Suarez et al.   JOURNAL OF NEUROSCIENCE

Parkinson's disease: convergence on synaptic homeostasis

(2018) Sandra‐Fausia Soukup et al.   EMBO JOURNAL

Tsix–Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function

(2018) Lieselot L. G. Carrette et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats

(2017) Juan Niu et al.   Journal of Neuroinflammation

GPR55: A therapeutic target for Parkinson's disease?

(2017) Marta Celorrio et al.   NEUROPHARMACOLOGY

AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice

(2017) Jun Shi et al.   Oncotarget

Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation-driven rat models of Parkinson's disease

(2016) Ruth M. Concannon et al.   EXPERIMENTAL NEUROLOGY

Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression

(2016) Xiaolie He et al.   International Journal of Nanomedicine

The roles of non-coding RNAs in Parkinson’s disease

(2016) Maryam Majidinia et al.   MOLECULAR BIOLOGY REPORTS

Apomorphine and levodopa in Parkinson's disease: Two revolutionary drugs from the 1950's

(2016) Atbin Djamshidian et al.   PARKINSONISM & RELATED DISORDERS

The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases

(2016) R. Coccurello et al.   Expert Review of Clinical Pharmacology

Epigenetic mechanisms in Parkinson's disease

(2015) Ya Feng et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection

(2015) Sandeep Vasant More et al.   Molecular Neurodegeneration

Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway

(2015) H. Dong et al.   NEUROSCIENCE

Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease

(2015) María Concepción García et al.   NEUROSCIENCE LETTERS

Time-Dependent Protection of CB2 Receptor Agonist in Stroke

(2015) Seong-Jin Yu et al.   PLoS One

Classics in Chemical Neuroscience: Levodopa

(2014) A. Connor Whitfield et al.   ACS Chemical Neuroscience

Medication Adherence in Patients with Parkinson’s Disease

(2014) Naveed Malek et al.   CNS DRUGS

Pharmacological Treatment of Parkinson Disease

(2014) Barbara S. Connolly et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model

(2014) Rosaria Greco et al.   JOURNAL OF HEADACHE AND PAIN

The high-affinity D2/D3 agonist D512 protects PC12 cells from 6-OHDA-induced apoptotic cell death and rescues dopaminergic neurons in the MPTP mouse model of Parkinson's disease

(2014) Mrudang Shah et al.   JOURNAL OF NEUROCHEMISTRY

Cannabinoid CB2receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice

(2014) Hai-Ying Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases

(2013) Ping Wu et al.   BRAIN RESEARCH BULLETIN

Animal models of Parkinson’s disease

(2012) Fabio Blandini et al.   FEBS Journal

Chronic blockade of cannabinoid CB2 receptors induces anxiolytic-like actions associated with alterations in GABAA receptors

(2011) María S García-Gutiérrez et al.   BRITISH JOURNAL OF PHARMACOLOGY

Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo

(2011) Koen Van Laere et al.   NEUROBIOLOGY OF AGING

Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson's disease in the rat

(2010) Sinéad Walsh et al.   BRAIN RESEARCH BULLETIN

CB2: a cannabinoid receptor with an identity crisis

(2010) Brady K Atwood et al.   BRITISH JOURNAL OF PHARMACOLOGY

Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine

(2010) Alexander Ternianov et al.   NEUROBIOLOGY OF AGING

Role of activated endocannabinoid system in regulation of cellular cholesterol metabolism in macrophages

(2008) L.-s. Jiang et al.   CARDIOVASCULAR RESEARCH

Recent Advances in the Development of Selective Ligands for the Cannabinoid CB2 Receptor

(2008) John Huffman et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY